Andrew Meyer, DO
Hematology & Oncology · Lawrence, KSNPI 1750601084
Payments from drug & device makers
Across 18 payments — averaging $27.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$169
- Merck$126
- Novartis$66
- Sanofi$50
- AstraZeneca$43
- Puma Biotechnology, Inc.$29
- plus $12 from 1 others
What the payments were for
- Speaking & faculty fees$5010%
- Food & beverage$12125%
- Education$32465%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 2 | $169 |
| Merck | 7 | $126 |
| Novartis | 4 | $66 |
| Sanofi | 1 | $50 |
| AstraZeneca | 1 | $43 |
| Puma Biotechnology, Inc. | 2 | $29 |
| Gilead | 1 | $12 |
How this compares
$495 in reported general payments places this provider in the 20th percentile of 97 hematology & oncology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KrazatiAdagrasib | 13 | $254,980 |
| RevlimidLenalidomide | 19 | $224,967 |
| ImbruvicaIbrutinib | 13 | $193,511 |
| IbrancePalbociclib | 12 | $193,341 |
| Lenalidomide | 17 | $182,320 |
| BrukinsaZanubrutinib | 12 | $181,696 |
| EliquisApixaban | 110 | $69,346 |
| OrgovyxRelugolix | 12 | $32,537 |
| Abiraterone Acetate | 19 | $26,618 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 61 | $2,226 |
| Tamoxifen Citrate | 113 | $1,849 |
| Anastrozole | 170 | $1,488 |
| Morphine Sulfate ErMorphine Sulfate | 28 | $991 |
| Hydroxyurea | 39 | $957 |
| Imatinib Mesylate | 11 | $872 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Lawrence
- Jodie BarrLawrence$10K
- Sharon SouleLawrence$2K
- Priyanka SharmaWestwood$18.5M
- Anup Kumar Kasi Loknath KumarWestwood$15.3M
- Marc HoffmannOverland Park$13.6M
- Shaker DakhilWichita$11.2M
- Sunil AbhyankarWestwood$5M
- Joseph McGuirkKansas City$3.1M
- Prakash NeupaneWestwood$2.7M
- Joseph StilwillOverland Park$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.